메뉴 건너뛰기
Archives of Ophthalmology
Volumn 123, Issue 7, 2005, Pages 1021-1022
Incorporating the results of the ocular hypertension treatment study into clinical practice [4]
Author keywords

[No Author keywords available]
Indexed keywords

BLINDNESS; BLOOD PRESSURE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; INTRAOCULAR HYPERTENSION; LETTER; LIFE EXPECTANCY; OPEN ANGLE GLAUCOMA; POLICY; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; VISUAL IMPAIRMENT; DRUG EFFECT; INTRAOCULAR PRESSURE; NOTE; RISK FACTOR;
EID: 22844448056     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.7.1021-b     Document Type: Letter
Times cited : (6)
References (5)
  • 1
    • 1542348335 scopus 로고    scopus 로고
    • The Ocular Hypertension Treatment Study: Intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease
    • published erratum appears in Arch Ophthalmol 2004;122;1039
    • Robin AL, Frick KD, Katz J, Budenz D, Tielsch JM. The Ocular Hypertension Treatment Study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease [published erratum appears in Arch Ophthalmol. 2004;122;1039]. Arch Ophthalmol. 2004;122:376-377.
    • (2004) Arch Ophthalmol , vol.122 , pp. 376-377
    • Robin, A.L.1    Frick, K.D.2    Katz, J.3    Budenz, D.4    Tielsch, J.M.5
  • 2
    • 1542348334 scopus 로고    scopus 로고
    • We should treat fewer patients with elevated intraocular pressure now that we know the results of the Ocular Hypertension Treatment Study
    • Jampel HD. We should treat fewer patients with elevated intraocular pressure now that we know the results of the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2004;122:378-379.
    • (2004) Arch Ophthalmol , vol.122 , pp. 378-379
    • Jampel, H.D.1
  • 3
    • 0036269833 scopus 로고    scopus 로고
    • The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
    • Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
    • (2002) Arch Ophthalmol , vol.120 , pp. 701-713
    • Kass, M.A.1    Heuer, D.K.2    Higginbotham, E.J.3
  • 4
    • 0036272299 scopus 로고    scopus 로고
    • The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma
    • Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
    • (2002) Arch Ophthalmol , vol.120 , pp. 714-720
    • Gordon, M.O.1    Beiser, J.A.2    Brandt, J.D.3
  • 5
    • 0036713544 scopus 로고    scopus 로고
    • The European Glaucoma Prevention Study: Design and baseline description of the participants
    • Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I; European Glaucoma Prevention Study Group. The European Glaucoma Prevention Study: design and baseline description of the participants. Ophthalmology. 2002;109:1612-1621.
    • (2002) Ophthalmology , vol.109 , pp. 1612-1621
    • Miglior, S.1    Zeyen, T.2    Pfeiffer, N.3    Cunha-Vaz, J.4    Torri, V.5    Adamsons, I.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.